Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Opening Hours
Collections
Help Via Email

Electronic Information Resources

Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents

详细信息查看全文

作者：Chan Kyu Kim^a ; Dong Hoon Han^a ; Young Seok Ji^a ; Min Sung Lee^a ; Chang Wook Min^a ; Seong Kyu Park ; MD PhD^a ; ^{skpark@schmc.ac.kr" class="auth_mail" title="E-mail the corresponding author} ; Se Hyung Kim^a ; Jina Yun^a ; Hyun Jeung Kim^a ; Kyoung Ha Kim^b ; Kyu Taek Lee^c ; Jong Ho Won^b ; Dae Sik Hong^a ; Hee Kyung Kim^d
关键词：Myelodysplastic syndrome ; Angiogenesis ; Biomarker ; Hypomethylating agent
刊名：Leukemia Research
出版年：2016
出版时间：November 2016
年：2016
卷：50
期：Complete
页码：21-28
全文大小：1363 K

文摘

•: The role of angiogenesis in MDS has not been clearly revealed.
•: Microvessel density (MVD) of RCUD was significantly lower than in other MDS types.
•: MVD was closely associated with the responsiveness to hypomethylating agents in MDS.
•: Angiogenesis related markers might be potentially prognostic factors for MDS.

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.